Bougainville Ventures Inc. Signs Definitive Agreement to enter in to Funding and Asset Purchase Agreement of 39% with Thrive Nutrition Products Ltd.

Vancouver, British Columbia–(Newsfile Corp. – September 24, 2019) – BOUGAINVILLE VENTURES INC. (CSE: BOG) (OTC Pink: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that further to the letter of intent (“LOI”) with Thrive Nutrition Products Ltd. (“Thrive Nutrition”) announced in the Company news release dated August 6, 2019 the Company signed a definitive agreement to complete the acquisition of Thrive Nutrition (“the Thrive Nutrition Transaction”). Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS” brand.


The total consideration will consist of common shares of Bougainville equivalent to $819,000 CDN. Subject to completion of the Thrive Wellness Transaction the board of directors of Bougainville will approve the Company to deliver the common shares of Bougainville to Thrive Nutrition, which will satisfy Bougainville’s obligation under the Thrive Nutrition Transaction. The consideration is to be payable in such number of common shares equivalent to $819,000 CDN in its share capital (“Consideration Shares”) at a per share price equal to the volume weighted average price of such shares on the Canadian Securities Exchange over a 15-day period ending on the day such Consideration Shares are required to be issued (“15 day VWAP”). The final evaluation was determined by an independent third party evaluator, which valued the business at $2,100 000 CDN. The Company will acquire 39% of Thrive Wellness assets and current inventory.

About Thrive Nutrition Products Ltd.

Thrive Wellness is a distributor of premium hemp and natural health products with operations currently in Canada and the USA. Thrive specializes in the development, marketing and distribution of cannabinoid products refined into their own natural health product brand. The company was founded in Vancouver, British Columbia and is the first of its kind with national retail distribution in Canada. Thrive has achieved $2,500,000 CDN in sales through retail distribution, its’ e-commerce website and their relationship with Nutrition House, Canada’s leading Natural Health Product franchise. Founded in 1979 the company began franchising in 1993 and now operates over 45 retail stores, located in high profile shopping centers across Canada, and in the USA.

CEO, Andy Dhaliwal Comments:

“I am very excited to be joining the Bougainville team and happy to see the merger of our to companies happening at a time when the CBD market is set to explode. My objective is to have our two companies grow across multiple platforms in the CBD market, from oils, topical and drinks to fibers and eventually processing the many products derived from the Hemp plant.”

To learn more about what this news means to the shareholders visit, as well as on the company’s site.

About the CBD Market

Bank of America projects a spend of $1.3 Billion on CBD in Canada by 2022, while $1.9 Billion is being spent in the USA currently, and another $4.4 Billion in Europe this year. Demand for CBD and Hemp is increasing year over year, with Merrill Lynch predicting an $11.5 Billion American market by 2032.

About Bougainville Ventures, Inc.

Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington state, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors


Andy Jagpal, President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305 Or toll free at 1- 877-517-7816


FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward- looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

To view the source version of this press release, please visit